ProFound AI® Risk

Revolutionizing Personalized Screening

Now available for 2D and 3D mammography

Risk Assessment Reimagined

ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate1,2 short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.

The easy-to-implement solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.

ProFound AI Risk uniquely combines a range of risk factors, offering superior performance and accuracy in assessing short-term risk compared to traditional, commonly-used breast cancer risk models.1,2

Next Level Insights

The latest generation of ProFound AI Risk offers unprecedented insights for clinicians and patients:

Flexibility to calculate a one, two, or three-year absolute risk and risk category for the woman and compares her risk relative to the average risk for women in her age group (country specific)

Designed to offer greater accuracy and ethnically inclusive precision screening

More than 15 country-specific incidence and mortality rates for alignment with the country’s general population